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Summary 
Automation and oxygen tension control are two tools, which provide significant 
improvements to the reproducibility and efficiency of stem cell productions processes. 
Aim: The aim of this study was to establish a novel automation platform capable of 
controlling oxygen tension during both the cell culture and liquid handling steps of neural 
differentiation processes. Materials and Methods: We built a bespoke automation 
platform, which enclosed a liquid handling platform in sterile, oxygen-controlled 
environment. An airtight connection was used to transfer cell culture plates to and from 
an automated oxygen-controlled incubator. Results: Our results demonstrate that our 
system yielded comparable cells numbers, viabilities, metabolism profiles and 
differentiation efficiencies when compared with traditional manual processes. 
Interestingly, eliminating exposure to ambient conditions during the liquid handling stage 
resulted significant improvements in the yield of MAP2 positive neural cells indicating 
that this level of control can improve differentiation processes. Conclusions: This article 
describes, for the first time, an automation platform capable of maintaining oxygen 
tension control during both the cell culture and liquid handling stages of a two 
dimensional differentiation process. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
1 Introduction  
 
 Embryonic stem cells (ESC) are currently being evaluated for potential 
application in a number of diverse areas including regenerative medicine [1], drug 
discovery and development [2-4] and as routes for delivery of gene therapies [5]. The 
high level of interest is a consequence of the ability of ESCs to self renew indefinitely 
and to differentiate into most adult cell types [6-10]. The production of differentiated cell 
types from ESC will be reliant upon robust, reproducible and high yield cell culture 
processes [1, 11,12]. Automated bioreactors have historically allowed the control of 
mammalian suspension cell culture resulting in repeatable and controlled bioprocesses 
[13,14]. Although a number of studies have used microcarrier technologies to 
differentiate ESC in suspension bioreactors [15-22] the vast majority of current 
differentiation protocols are based on 2D cell cultures.  
A number of reports have used commercially available automation platforms for 
the maintenance of stem cells under 2D culture conditions [12, 23-28]. By eliminating 
reliance upon highly skilled operators these systems can enhance the reproducibility of 
stem cell bioprocesses. However, these automated platforms do not control the exposure 
of cells to key gaseous components, such as oxygen, during the robotic liquid handling 
steps of ESC culture.  
Physiological oxygen levels that occur during early embryo development have 
been shown to maintain ESC in a pluripotent state [29-31] and to improve their directed 
differentiation towards cardiac [15, 20], vascular [32], neural [33-37] and retinal lineages 
[38]. Studies from our laboratory revealed that the yield of neural cells from mouse ESC 
(mESC) can be greatly enhanced by manually operating at 2% O2 [33]. However, the 
oxygen tension at the growth surface rose to 21% O2 during medium exchanges. It took 
approximately 5 h for the oxygen tension at the growth surface to return to 2% O2 once 
the cell culture dishes had been returned to a hypoxic environment. The biological 
repercussions of these transient shifts in oxygen remain unclear. In a separate study we 
also revealed that both the expansion and differentiation of mESCs were sensitive to 
shifts in pH and temperature which were detected when cells are removed from the 
incubator and processed under ambient conditions [39]. 
In this article, we present a novel automation platform for 2D stem cell culture 
capable of controlling oxygen tension during the medium exchange step. By integrating 
an oxygen controlled incubator into the platform we were able to maintain 2% O2 during 
both the culture and liquid handling steps. Using this system, mESC were differentiated 
into neural cells whilst maintaining 37
o
C, 5% CO2 and 2% O2 throughout the entire 8 day 
differentiation protocol. 
 
2 Methods and Materials 
 
2. 1 Undifferentiated cell culture  
 
 E14Tg2a mESC, kindly donated by Stem Cell Sciences Ltd (Cambridge, UK), 
were maintained in culture at 37C and 5% CO2 under sterile conditions in a Heraeus 
Hera-Cell 150 incubator (Jencons-PLS, West Sussex, UK). Cells were grown in 5 ml of 
culture media on Iwaki T25 tissue culture treated flasks (SLS, Nottingham, UK) coated 
with 0.1% gelatin (Sigma, Poole, UK). The culture media was composed of: 450 ml of 
Glasgow minimal essential media (GMEM) supplemented with 500 l of 0.1 M 2-β-
mercaptoethanol (both Sigma), 50 ml foetal bovine serum, 5 ml non-essential amino 
acids, 5 ml of 200 mM L-glutamine and 5 ml of 100 mM sodium pyruvate (all Invitrogen, 
Paisley, UK). After sterilization by filtration the media was supplemented with 0.5 ml of 
1x10
6
 units.ml
-1
 leukemia inhibitory factor (LIF, Millipore, Hertfordshire, UK). Cells 
were passaged after 2 days of culture by removing spent media followed by a gentle wash 
with Dulbecco’s phosphate buffered saline without Ca2+/Mg2+ (DPBS, Sigma). Cells 
were detached with a solution of 0.025% trypsin, 0.04% ethylenediaminetetraacetic acid 
(EDTA, all Invitrogen) and 0.9% chick serum (Sigma) dissolved in DPBS. After 3 
minutes of tripsinization at 37°C, 3 ml of fresh growth media were added to quench the 
trypsin. Cells were centrifuged for 3 minutes at 300 g, resuspended as a single cell 
suspension in growth media and re-inoculated into a new T25 flask pre-coated with 
gelatin. The E14Tg2a mESC used in all experiments were between passage 15 and 
22. Oct3/4 and Nanog pluripotency marker expression were used to assess the 
quality of the cells by immunocytochemistry (ICC) (Supplementary Figure 1). 
 
2.2 Neural Differentiation Protocol 
 
 Monolayer neural differentiation was based on the method reported by Ying et al., 
[40]. Undifferentiated stem cells were harvested after 2 days of culture by tripsinization. 
Trypsin was quenched with fresh culture media without LIF. The resulting cell 
suspension was centrifuged for 3 min at 300g, resuspended in NDIFF-RHBA 
differentiation culture media (Stem Cells Sciences). Cells were plated in 2 ml of medium 
at a density of 2 x 10
4
 cells.cm
-2
 in Iwaki tissue culture treated six-well plates (SLS, 
Nottingham, UK) pre-coated with 0.1% gelatin (Sigma). Each well was replenished with 
2 ml of NDIFF-RHBA media every 2 days in a laminar flow hood operating under 
normal atmospheric conditions over a total 8-day culture period. Manually seeded six-
well plates were also transferred to hypoxic chambers and the automated incubators for 
processing at 2% O2. When required cells were trypsinized and gently resuspended with a 
Pasteur glass pipette to recover a single cell suspension for further analysis.  
 
2.3 Description of the automation platform  
 
A Tecan Freedom EVO 100 liquid handling platform (Tecan, Mannedorf, 
Switzerland) was used to automate medium exchanges during the neural differentiation 
protocol. The platform was contained within an enclosed class II biological safety cabinet 
(Walker Safety Cabinets, Derbyshire, UK) (Figure 1.a). This system has the capability to 
control temperature, O2 and CO2 during liquid handling stages.  Airtight connections 
were used to integrate a microplate centrifuge (Hettich Rotanta 46 RSC, Bach, 
Switzerland) and an automated Thermo Cytomat C450S incubator (Thermo-Fisher, 
Basingstoke, UK). The incubator was equipped with a 32 plate position rack, 
temperature, O2, CO2 and humidity control and a robotic arm for the selection and 
transport of culture plates to the liquid handling platform. The liquid handling platform 
was composed of the following devices: liquid handling arm with 4 channels and 
integrated level liquid detection (LID), robotic manipulator arm (RoMa), robotic 
transport arm (Te-Link), tilting plate holder and a media reservoir station consisting of 2 
x 500 ml and 5 x 100 ml wells designed to accept sterile disposable medium containers 
(Tecan) (Figure 1.b). The liquid handling arm was equipped with 1 mL syringes, which 
were used with 1 ml disposable tips  (Tecan). Disposable tips and fresh medium were 
transferred onto the robot deck using an airlock which was located to the left of the 
platform (Figure 1a). All the robotic arms and tilting plate holder were controlled through 
Freedom EVOware 2 plus software (Tecan).  
 
2.4 Automated processing parameters 
  
In order to avoid the exposure of differentiating cells to ambient conditions during 
the liquid handling steps the environment within the class II safety cabinet was 
maintained at a set point of 37ºC, 5% CO2 and 2% O2. Every 48 hours plates were 
transported onto the liquid handling platform by the incubator’s robotic arm with a 
maximum speed of 500 mm.s
-1
 and placed in the same position through the use of a 
sensor with an accuracy of ± 0.5 mm. Plates were picked up from the robot arm by the 
Te-link transporter arm, using a 10-15 N gripper force, and transferred to the tilting plate 
holder. The tilting plate holder moved at a speed of 100 mm·s
-1 
until it reached a position 
of 30º relative to the robotic deck. At this position, all the spent medium was removed by 
aspiration and replaced by fresh medium that had been allowed to equilibrate for at least 
5 hours on the robot deck. The speed of aspiration to discard and dispense media during 
culture media renew was 150 ± 7.5 l·s-1 under a pipetting working pressure of 1 mPa. 
Tips were positioned at the corner of the plate, 5 mm from the culture surface of the tilted 
plate with a separation of 38 mm between tips, this enabled simultaneous multiple well 
processing. Figure 2 shows an overview of all the stages involved in automated 
processing.  
 
2.5 Oxygen tension measurements 
 
The oxygen tension was measured using the Presens Oxy-4 system in conjunction with 
Sp-pst3-NAU-D5-NOP oxygen sensor spots (both Presens, Regensburg, Germany).  
Presens' detection principle is based on the quenching of fluorescence caused by collision 
between molecular oxygen and oxygen sensitive fluorescent dye molecules. The 
fluorescent dye molecules are immobilized in the form of a spot and coated with an 
optical insulation to avoid interference from intrinsic fluorescence. An oxygen sensor 
spot was used to monitor the oxygen tension at the growth surface of 6 well plates. The 
spots were placed at the base of individual wells before being submerged with 2 ml of 
NDIFF-RHBA differentiation media. The 6 well plates were placed in the automated 
incubator and the liquid handling platform under operation at 2% O2, 5% CO2 and 37
o
C.  
The Oxy-4 system and sensor spots were calibrated before each experiment in accordance 
with the manufacturer’s instructions which can be found at www.presens.de.  
 
2.6 Oxygen tension control for manual processing 
 
Oxygen control was achieved by the use of an in-house developed hypoxia 
chamber [33]. Hypoxia chambers were able to hold up to 3 x 6-well plates and a 10 cm 
diameter Petri dish (SLS) containing 5 ml of sterile H2O for humidification. Once the 6 
well plates and Petri dish were placed inside the hypoxia chamber, a removable cover 
was attached, tightly sealed and purged with the premixed gas containing 2% O2 
supplemented with 5% CO2 and balanced with 93% N2 (BOC, London, UK). Hypoxia 
chambers had a filter-inlet and outlet of gas to allow sterile gassing of the system 
performed for 5 min at a flow rate of 7.5 l.min
-1
, after which the tubing was sealed using 
two screw clamps. Gassed and sealed hypoxia chambers were placed in incubators to 
control temperature at 37°C during the culture period.  
 
2.7 Cell number and viability 
 
Cell number and viability was measured every 48 hours using Guava ViaCount 
reagent (Millipore, California, US) according to manufacturer’s instructions. Samples 
were analyzed on a Guava
 
EasyCyte 96-well flow cytometer using Cytosoft 3.6.1 – 
Express Plus software to detect and calculate cell number and viability.  
 
2.8 Immunocytochemistry 
 
Immunocytochemistry (ICC) analysis was performed at the end of the 8 day 
differentiation protocol. NDIFF-RHBA spent media was discarded and samples were 
gently washed with DPBS for 5 minutes followed by fixation with 4% para-formaldehyde 
(Sigma) for 20 minutes at room temperature. After the fixation step, cells were gently 
washed with DPBS and incubated during 30 minutes with permeation solution composed 
of 0.25% Triton X100 in DPBS without Ca
2+
/Mg
2+
 (Sigma). The permeation solution was 
subsequently discarded and cells were incubated at room temperature for 60 minutes with 
primary antibody. Primary antibodies anti-MAP2 (1:500), anti-III tubulin (1:400, both 
Sigma), anti-Nestin (1:300, Millipore), anti-Oct3/4 (1:200, Santa Cruz) and anti Nanog 
(1:300, Abcam) were diluted in blocking solution composed of 0.25% Triton X100 and 
2% goat serum in DPBS without Ca
2+
/Mg
2+
 (Sigma). Mouse IgG2b isotype control for 
III tubulin and mouse IgG1 isotype control (both Sigma) for Nestin and MAP2 were 
used at the same dilution as the corresponding primary antibodies. Cells were washed 
twice for 5 minutes with DPBS to discard the excess of primary or isotype antibodies. 
Anti-mouse IgG (Fc Specific) FITC conjugate (Sigma) diluted 1:400 in blocking solution 
was used as secondary antibody by incubation for 60 minutes at room temperature 
followed by 2 wash steps with DPBS for 5 minutes. Samples were stained with a 4',6-
diamidino-2-phenylindole (DAPI) solution at a concentration of  1g∙ml-1 for 5 minutes 
for nuclei identification. An inverted fluorescent Nikon Eclipse TE2000-U microscope 
was used for image recording. High resolution images of MAP2 and III tubulin staining 
are shown in Supplementary Figure 2 confirming the correct localization of each 
antibody. The number and diameter of III tubulin positive neural rosettes from 30 
random fields of view was evaluated in triplicate wells. Neural rosettes were manually 
counted for each field of view. The diameter was obtained using image-processing 
software (Image J, NIH, USA) by measuring the maximum and minimum diameter of 
each neural rosette before calculating the mean value.  
 2. 9 Flow cytometry analysis of marker expression 
 
  At the end of differentiation protocol (8 days) cells were stained for nestin, III 
tubulin and MAP2 using the ICC method previously described without DAPI staining. 
Immunostained samples were trypsinised for 5-10 minutes at 37°C. In order to obtain a 
single cell suspension for flow cytometry analysis, cells were gently re-suspended using a 
Pasteur glass pipette. Samples were analyzed on a Guava
 
EasyCyte 96-well flow 
cytometer using Cytosoft 3.6.1 – Express Plus software. Cells immunostained with 
isotype controls were used to gate the negative population allowing the detection of 99 % 
population expressing each of the neural markers. 
 
2.10 Metabolite analysis 
  
 Nova Bioprofile 400 instrument (Nova Biomedical, Flintshire, UK) was used to 
determine levels of glucose, lactate and ammonium in the spent media. These 
measurements were used to calculate molar concentrations at specific time points as well 
as to calculate specific rates of consumption and production.  Instrument calibration 
according to manufacturer’s instructions was always performed prior to sample 
measurements.  
 
2.11 Calculation methods  
 
2.11.1 Specific growth rate () and doubling time (td) 
                                              
The specific growth rate () values were calculated during the exponential phase of the 
culture (from day 4 to day 8 post seeding) using equation 1: 
 
                                                                                                                1 
 
 
 
 
Where  corresponds to the specific growth rate value at any given time interval Δt (in 
days, between sampling points i-1 and i), and X (cells) is the value of viable cells at each 
corresponding time point. The exponential phase of each culture condition allowed the 
calculation of 3 specific growth rate values from which the average and standard 
deviation were calculated and presented in reciprocal days (day
-1
). 
 
From equation 1 the doubling (td) time was calculated as follows: 
 
                                                                                                                             2                                                              
 
  
 
 
2.11.2 Calculation of the specific rates of glucose consumption and lactate production (q) 
 The specific production and consumption rates of glucose and lactate were calculated 
using equation 3: 
     
 
                                                                                                       3 
Where q (in pmol.cell
-1
.day
-1
) represents the specific consumption (for glucose) or 
production rate (for lactate), ΔC is the change in the concentration of glucose or lactate 
(Ct-1-Ct and Ct-Ct-1, respectively), Δt is the corresponding time and Xave is the average 
volumetric cell concentration between i-1 and i. The specific rates are presented in 
pmol.cell
-1
.day
-1
 
 
2.11.3 Calculation of the fold increase in cell density 
 
The fold increase in cell density was calculated using equation 4 
 
FI    =     X2%O2 P2%O2 
      X20%O2 P20%O2                                                                                               4                                                                                                      
  
Where: 
X2%O2 is the viable cell density at 2%O2 (either manual or automated).  
P2%O2 is the percentage of cells expressing each marker (nestin, III tubulin or MAP2) at   
2% O2 (either manual or automated).  
X20%O2 is the viable cell density at 20% O2 condition 
P20%O2 is the percentage of cells expressing each marker (nestin, III tubulin or MAP2) at 
20% O2 condition. 
 
2.13 Statistical analysis 
 
Three replicates were performed for all cell culture experiments. Error bars 
represent one standard deviation above and below the mean. Significant differences 
between data points were calculated using a two-tailed, paired, student t-test. P values of 
less than 0.05 were deemed to be significant. 
 
3. Results  
 
In order to investigate the impact of environment-control during cell culture liquid 
handling steps, we compared the neural differentiation of mESC under three conditions. 
Cell culture plates were either cultured in an incubator under atmospheric conditions 
(20% manual), in hypoxic chambers (2% manual) or in the automated incubator 
operating at 2% O2 (2% automated). In the case of 20% manual and 2% manual 
conditions, medium exchanges were carried out manually in a laminar flow hood 
operating under atmospheric conditions. Plates being cultured in the 2% automated 
condition were moved onto the environmentally controlled automation platform for 
medium exchanges as outlined in the Materials and Methods. We measured the oxygen 
tension in the liquid phase of culture plates placed in either the cytomat incubator or on 
the Tecan Evo platform during operation under the 2% automated condition. 2% O2 was 
measured in both as shown in Figure 1c. These results confirm that our automation 
platform was capable of operating under hypoxic conditions during both the cell culture 
and liquid handing phases of the process. 
 
3.1 The effect of automated bioprocessing on neural rosette formation 
 
 
Neural cells obtained during the directed differentiation of mESC tend to form 
colonies known as neural rosettes (Ying et al., 2003). In order to investigate the effect of 
automated culture on the morphology of neural rosettes, cells were fixed after 8 days of 
differentiation and stained for III tubulin expression (Figure 3). These results show that 
the 2% O2 automated process successfully resulted in the formation of III tubulin 
positive neural rosettes.  There was a 3.5 fold increase in rosette density at 2% O2 manual 
as compared with 20% O2 manual (p < 0.05) (Figure 4a). Importantly there was no 
significant difference between the rosette density or diameter (Figure 4b) at 2% O2 
manual compared with 2% O2 automated (p > 0.05) confirming that the automation 
process had not affected the formation of neural rosettes.  
 
3.2 The effect of automated bioprocessing on the yield and purity of the process  
 
After 8 days of differentiation under all three conditions cells were detached to 
analyse the final cell number and viability. The 2% O2 manual process yielded 3 fold 
more viable cells than the 20% O2 manual process (p < 0.05). Similar final cell numbers 
were obtained for 2% O2 manual and 2% O2 automated processes yielding 2.37 ± 0.24 x 
10
5 cells∙cm-2 and 2.27 ± 0.18 x 105 cells∙cm-2 respectively (p > 0.05)  (Figure 5a). The 
expression of one neural stem cell marker (Nestin) and two neuronal markers (III 
tubulin and MAP2) were assessed by flow cytometry at the end of differentiation 
protocol. The percentage of cells expressing Nestin and III tubulin was very similar 
when comparing 2% O2 manual and 2% O2 automated processes (p > 0.05). The 2% O2 
automated process resulted in 21 ± 2 % of the final population expressing MAP2. This 
represented a 3-fold increase in MAP2 expression as compared with 2% O2 manual (p < 
0.05) and a 7-fold increase in MAP2 expression when compared to 20% O2 manual (p < 
0.05) processes (Figure 5b). A similar trend was observed for the cellular density of each 
neural population, which was calculated by multiplying the final cell number under each 
condition with the percentage of cells expressing each marker (Figure 5c). There were no 
significant differences between the density of Nestin and III tubulin positive cells when 
comparing 2% O2 manual with 2% O2 automated processes. A 3 fold increase in density 
of III tubulin positive cells was obtained when 2% O2 manual and 2% O2 automated 
were compared with the 20% O2 manual condition (p < 0.05). The density of MAP2 
positive cells in the 2% O2 automated process was 16 fold higher than 20% O2 manual, 
whilst the density of MAP2 positive cells in the 2%O2 manual condition was 6 fold 
higher than 20% O2 manual (both p < 0.05) (Figure 5C). In summary, these results 
indicate that the automated platform was capable of achieving similar cell densities to the 
manual process. The increase in MAP expression may be due to the elimination of 
transient exposure to 21% O2 during medium exchanges. Finally, it is worth noting that in 
this current study we only assessed 3 markers. There may be many other oxygen-
sensitive lineages which could be present in the final population (i.e. pluripotent cells and 
other differentiated lineages). In addition, there may have been significant co-expression 
between the different markers sets during the ESC differentiation process.  
 
 
 
3.3 The effect of automated bioprocessing on cell growth 
 
In order to further investigate the impact of environmentally controlled automated 
medium exchanges we sacrificed a 6 well plate every 2 days to measure cell density and 
cell viability under all three conditions. At days 6 and 8 of culture the cell density values 
were significantly lower in the 20% manual processing culture condition, when compared 
to both hypoxic cultures (Figure 6a). Comparisons of the cell growth curves revealed that 
the expansion of cells was very similar in both the 2% manual and 2% automated 
processes although cell growth may have been slightly slower in the manual condition. 
For further analysis of cellular metabolism we considered the first 4 days of culture as the 
lag phase followed by an exponential phase from 4 days to 8 days based on the growth 
curves.  The specific growth rates were calculated for the exponential phase as indicated 
in equation 1 and were found to be, 0.5 ± 2, 0.6 ± 0.2 and 0.4 ± 0.1 day
-1
 for the 2% 
automated, 2% manual and 20% O2 manual conditions.  There were no statistically 
significant differences between the growth rate of 2% automated and 2% manual O2 
culture conditions. 
 
3.4 The effect of automated bioprocessing on cell metabolism 
 
In addition to cell growth, cell metabolism was monitored for the three different 
culture conditions every 2 days during the 8 days of differentiation protocol. Glucose 
consumption, lactate production, and ammonia concentrations are shown in Figure 6 b-d.  
A linear decrease in glucose consumption and lactate production was detected over the 
whole period of culture for all processing conditions with no statistical differences except 
for day 2, where lactate production was higher in the 2% O2 manual condition, when 
compared to the other culture modes (Figures 6b and 6c). Specific rates for glucose 
consumption and lactate production are in agreement with values from the literature [41, 
42]. These results indicate that the automation platform did not interfere with glucose 
metabolism. Analysis of ammonia concentrations (figure 6d) revealed that differentiation 
at 20% O2 caused the accumulation of this metabolite to potentially toxic levels [49]. 
Under both 2% O2 manual and automated conditions ammonia levels were remained 
relatively low in comparison. Lower levels of toxic ammonium may have contributed to 
the higher levels of viability observed at 2% O2 [33]. 
 
 4 Discussion 
 
Cell culture automation has improved over the years and systems have been 
integrated into production lines enhancing industrial (i.e. pharmaceutical) production in 
terms of efficiency and productivity. Barrier isolators and cGMP conditions have been 
adapted for pharmaceutical and biotechnological processing avoiding cross-
contamination and operator exposure [26]. A number of studies have previously 
demonstrated that commercially available automation platforms can be used to develop 
robust stem cell production processes based on two dimensional cell culture systems [12, 
23-28]. Automated platforms enable accurate and repeatable control of plate handling and 
liquid handling velocities and forces. This will allow processes to avoid variable 
exposure to shear stresses, which can influence ESC differentiation [44-46]. In addition, 
automated technology avoids contact with human operators thus minimizing a potential 
source of contaminations [47]. In this study we demonstrate that automation platforms 
can be used for the two dimensional differentiation of ESC. We envisage that the type of 
closed system we employed could be used for a range of differentiation processes many 
of which are highly irreproducible and labour intensive. The majority of human ESC 
neural differentiation processes rely upon two stage processes. Firstly aggregates known 
as embryoid bodies are grown in suspension before being allowed to attach into two 
dimensional culture format for final maturation towards the target phenotype. A number 
of groups have already demonstrated the use of stirred tank bioreactor technologies for 
the culture of embryoid bodies in the first stage [17, 20]. For this type of process we 
envisage that automated cell culture platforms could now be used for the second part of 
the process. 
Our bespoke automation platform differs from commercially available systems in 
its ability to control oxygen tension during both the cell culture and the liquid handling 
stage. This allowed us to perform automated two-dimensional neural differentiations 
under oxygen-controlled conditions (2% O2). Physiological oxygen tension surrounding 
the early embryo during normal development is significantly lower than laboratory 
oxygen tensions commonly used in most ESC protocols (~20% O2) [33]. Measurements 
of oxygen tension in the uterus of several mammals ranged from 1.5 to 8.7% O2 [48], 
while oxygen tensions in the mature brain environment ranging from 0.1% to 5% O2 [49]. 
Mimicking the in-vivo microenvironment has been a powerful tool for increasing the 
efficiency of ESC differentiation into a wide range of cell types [15, 20, 32-38, 42]. 
Therefore, it is important that any new automation platform for ESC processing should 
have the ability to control this critical parameter. In a previous study we have shown that 
the yield of neural cells from mESC can be greatly enhanced by manually operating at 
2% O2 [33]. However, ESC differentiation processes typically require medium changes 
every other day (in some cases this can be daily). Using traditional hypoxic chambers the 
oxygen tension at the growth surface rose to 21% O2 during medium exchanges [33]. It 
took approximately 5 h for the oxygen tensions at the growth surface to return to 2% O2 
once the cell culture dishes had been returned to a hypoxic environment. Our automation 
platform was designed with this in mind and liquid handling steps were carried out at 2% 
O2. The data here revealed that our automation platform was capable of delivering a 
similar process to the manual control. One unexpected result was a 3-fold increase in the 
number of cells expressing the neuronal marker MAP2. We tentatively hypothesise that 
the formation of MAP2 positive cells is sensitive to exposure to ambient conditions and 
that eliminating these shifts resulted in an increase in this population. Our automated 
process did not affect the formation III-tubulin or Nestin positive populations indicating 
that eliminating transient shifts on oxygen does not have a beneficial impact on all neural 
lineages. This is in keeping with our previous results showing that the oxygen had a more 
pronounced impact on the formation of MAP2 positive cells when compared with III-
tubulin or Nestin [33, 50]. A more detailed time-course analysis of marker expression 
will be needed in order to further investigate whether the automation process affected the 
rate of differentiation. Taken together, these results demonstrate that transient shifts in 
oxygen tension to ambient conditions may inhibit some of the positive effects associated 
with differentiation under physiological conditions.  
In summary, we have shown for the first time that an automation platform can be 
used for the neural differentiation of embryonic stem cells in a two dimensional format. 
This is of particular importance given that many hESC, induced pluripotent stem cell 
(iPSC) and adult stem cell directed differentiation protocols rely upon this type of 
attached culture format for the generation of a wide variety of cells for regenerative 
medicine applications. Our system enables the transfer of labour intensive process, which 
are highly dependent upon operator to operator variability [39], into controlled, 
automated bioprocess. In addition, we exploited the system’s ability to control oxygen 
during the liquid handling steps to ensure that O2 levels remained consistent throughout 
the entire 8 day process.  
 
5 Executive Summary 
 
 We have developed a novel automation platform capable of controlling O2 during 
liquid handling steps. 
 The platform was tested on the neural differentiation of mouse embryonic stem 
under hypoxic conditions (2% O2) resulting in similar cellular yields when 
compared with the equivalent manual process. 
 There was a 3-fold increase in the number of cells expressing the neuronal marker 
MAP2 in the automated platform. 
 Glucose, lactate and ammonia metabolism was not affected by automated 
processing 
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FIGURE LEGENDS 
 
 
Figure 1. The automation platform used for the neural differentiation of mESC. (a) 
Photograph of liquid handling robot contained within a Class-II biosafety cabinet and 
integrated with and automated incubator and microplate centrifuge. (b) Photograph of the 
liquid handling plaform: RoMA (i), Te-Link (ii), tilting plate holder (iii), sterile media 
reservoir (iv), multi pipetting liquid handling arm (v) and sterile tips (vi). (c) Oxygen 
tension measurements at the growth surface of 6 well plates containing 2 ml of NDIFF-
RHBA on the liquid handling platform and within the Cytomat incubator during 
operation at 2% O2.  
 Figure 2.  Standard Operation Procedure (SOP) for automated neural differentiation of 
mESC. The cell culture and media renew steps were performed by Cytomat incubator and 
Tecan EVO automated platform respectively.  
 
Figure 3.  III tubulin staining for neural rosettes obtained from 20% manual, 2% 
manual and 2% automated processes after 8 days of differentiation. From left to right: 
bright field/phase contrast, DAPI staining for cell nuclei and III tubulin 
immunocytochemistry. Scale bars represent 100 m. 
 
Figure 4. Quantification of neural rosette formation after 8 days of differentiation. 
Rosette density per cm
2
 (a) and average diameter of neural rosettes (b) formed at 20% 
manual, 2% manual and 2% automated processes were evaluated from a total of 30 fields 
of view taken from three independent wells.  Rosettes that expressed III tubulin were 
assessed with the aid of image processing analysis in Java (Image J, NIH, USA). Error 
bars represent one standard deviation about the mean of three independent data points (n 
= 3).  Statistical analysis has been indicated as p < 0.05 (*). 
 
Figure 5. The yield and purity of neural cells produced after 8 days of differentiation 
under 20% manual, 2% manual and 2% automated conditions. (a) Viability and viable 
cell number after 8 days of differentiation and (b) The percentage of cells expressing 
Nestin, III-tubulin and MAP2 measured by flow cytometry. (c) represents the fold 
increase in the number of cells.cm
2
 expressing Nestin, III-tubulin and MAP2 at 2% 
manual and 2% automated as compared with 20% manual controls. Error bars represent 
one standard deviation about the mean of three independent data points (n = 3). Statistical 
analysis has been indicated as p < 0.05 (*). 
 
Figure 6. Cell growth and metabolism during the automated neuronal differentiation of 
mESC. Growth curve for manual and automated conditions showing total viable cell 
number (a), specific glucose consumption (b) and lactate production (c) rates, in 
pmol.cell
-1
day
-1
, and the cumulative production of ammonia (d), in mM,  measured every 
2 days for 20% manual culture (■), 2% manual culture (●) and 2% automated culture 
(▲). Error bars represent one standard deviation about the mean of three independent 
data points (n = 3). 
 
Supplementary Figure 1.  Immunocytochemistry analysis of pluripotency marker 
expression in E14Tg2a cells. The left panel shows brightfield images and the right panel 
shows DAPI (Blue) merged with Oct3/4 (green) (a), Nanog (green) (b). Scale bar 
represents 100 m. 
 
Supplementary Figure 2. Immunocytochemistry analysis of III tubulin and MAP2 
expression after 8 days of differentiation at 2% O2 (manual condition).  The images are at 
40X magnification showing III tubulin (green) and DAPI (blue) in (a) and MAP2 
(green) and DAPI (blue) in (b). Scale bar represents 10 m. 
 
